Glucocorticoid receptor function suppresses insulin-like growth factor 1 activity in human KLE endometrial-like cells

In Vivo

Volumn 18, Issue 1, 2004, Pages 43-48

  Lembessis, Peter ^a   Kalariti, Niki ^a   Koutsilieris, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Glucocorticoid receptor; Insulin like growth factor 1; Insulin like growth factor binding protein 3; KLE cells; Type 1 insulin like growth factor receptor; Urokinase type plasminogen activator; Urokinase type plasminogen activator receptor

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UROKINASE; UROKINASE RECEPTOR;

APOPTOSIS; ARTICLE; BIOAVAILABILITY; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; ENDOMETRIOSIS; ENDOMETRIUM CELL; FEMALE; HUMAN; HUMAN CELL; MEDICAL DOCUMENTATION; PATHOPHYSIOLOGY; PERITONEAL FLUID; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

EID: 1342326228     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Giudice LC: Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil Steril 61: 1-17, 1994.
2. Giudice LC, Dsupin BA, Gargosky SE, Rosenberg RG and Irwin JC: The insulin-like growth factor system in human peritoneal fluid: its effects on endometrial stromal cells and its potential relevance to endometriosis. J Clin Endocrinol Metabol 79: 1284-1293, 1994.
3. Koutsilieris M and Michaud J: Characterization of human uterus-derived growth substances. In Vivo 4: 161-166, 1990.
4. Koutsilieris M, Allaire-Michaud A, Fortier M and Lemay A: Mitogen(s) for endometrial-like cells can be detected in human peritoneal fluid. Fertil Steril 56: 888-893, 1991.
5. Koutsilieris M, Niklinski W, Frenette G and Lemay A: Heparin-sepharose binding growth factors in peritoneal fluid of women with endometriosis. Fertil Steril 59: 93-97, 1993.
6. Koutsilieris M, Akoum A, Lazure C, Frenette G and Lemay A: N-terminal truncated forms of IGFBP-3 in the peritoneal fluid of women without laparoscopic evidence of endometriosis. Fertil Steril 63: 314-321, 1995.
7. Akoum A, Doillon C, Koutsilieris M, Dompierre L, Maheux R, Villeneuve M, Bergeron M and Lemay A: Human endometrial cells cultured in a type I collagen gel. J Reprod Med 42: 555-561, 1996.
8. Lemay A, Koutsilieris M, Akoum A and Maheux R: Role potentiel de facteurs mitogeniques et proteolytiques du liquide peritoneal dans physiopathologie de l'endometriose. Ref Gynecol Obstetr 5: 205-211, 1997.
9. Koutsilieris M, Lavergne E and Lemay A: Association of protease activity against IGFBP-3 with peritoneal fluid mitogens: possible implications for the ectopic growth of endometrial cells in women with endometriosis. Anticancer Res 17: 1239-1244, 1997.
10. Koutsilieris M, Mastrogamvrakis G, Lembessis P, Sourla A, Miligos S and Michalas S: Increased insulin-like growth factor I activity can rescue KLE endometrial-like cells from apoptosis. Mol Med 7: 20-26, 2001.
11. Oh Y, Muller HL, Lamson G and Rosenfeld RG: Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J Biol Chemistry 268: 14964-14971, 1993.
12. Reyes-Moreno C, Frenette G, Lavergne E, Boulanger J, Govindan MV and Koutsilieris M: Mediation of glucocorticoid receptor function by transforming growth factor beta 1 expression in human PC-3 prostate cancer cells. Prostate 9: 260-269, 1995.
13. Boulanger J, Reyes-Moreno C and Koutsilieris M: Mediation of glucocorticoid receptor function by the activation of latent transforming growth factor 1 in MG-63 osteoblast-like osteosarcoma cells. Int J Cancer 61: 692-697, 1995.
14. Muller HL, Oh Y, Gargosky SE, Lehrnbecher T, Hintz RL and Rosenfeld RG: Concentration of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3), IGF, and IGFBP-3 proteases activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis. J Clin Endocrinol Metabol 77: 1113-1119, 1993.
15. Koutsilieris M, Frenette G, Lazure C, Lehoux J-G, Govindan MV and Polychronakos C: Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases. Anticancer Res 13: 481-486, 1993.
16. Nonoshita LD, Wathen NC, Dsupin BA, Chard T and Giudice LC: Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and proteolyzed IGFBP-3 in embryonic cavities in early human pregnancy: their potential relevance to maternal-embryonic and fetal interactions. J Clin Endocrinol Metabol 79: 1249-1255, 1994.
17. Matsumoto T, Gargosky SE, Iwasaki K and Rosenfeld RG: Identification and characterization of insulin-like growth factor (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid. J Clin Endocrinol Metabol 81: 150-155, 1996.
18. Koutsilieris M, Reyes-Moreno C, Sourla A, Dimitriadou V and Choki I: Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblast lesions in hormone refractory prostate cancer. Anticancer Res 17: 1461-1466, 1997.
19. Koutsilieris M, Mitsiades M and Sourla A: Insulin-like growth factor 1 and urokinase-type plasminogen activator bioregulation system as a survival mechanism of prostate cancer cells in osteoblastic metastases: development of anti-survival factor therapy for hormone-refractory prostate cancer. Mol Med 6: 167-251, 2000.
20. Grimberg A and Cohen P: Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 183: 1-9, 2000.
21. Reyes-Moreno C, Sourla A, Chiki I, Doillon C and Koutsilieris M: Osteoblast-derived growth factors protect PC-3 human prostate cancer cells from adriamycin-apoptosis. Urology 52: 341-347, 1998.
22. Giudice LC, Milkowski DA, Lamson G, Rosenfeld RG and Irwin JC: Insulin-like growth factor binding proteins in human endometrium: steroid-dependent mRNA expression and protein synthesis. Clin Endocrinol Metab 72: 779-787, 1991.
23. Fernández-Shaw S, Barlow DH, Marshall JM, Starkey PM and Hicks B: Plasminogen activators in ectopic and uterine endometrium. Fertil Steril 63: 45-51, 1995.
24. Stewart CE and Rotwein P: Growth, differentiation and survival: multiple physiological functions of insulin-like growth factors. Physiol Rev 76: 1005-1026, 1996.
25. Akoum A, Lemay A, Paradis I, Rheault N and Maheux R: Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids. Hum Reprod 11: 2269-75, 1996.
26. Akoum A, Lemay A, Lajeunesse Y, Marois M and Koutsilieris M: Immunohistochemical localization of insulin-like growth factor-binding protein-3 in eutopic and ectopic endometrial tissues. Fertil Steril 72: 1085-1092, 1999.
27. Lembessis P, Miligos S, Michalas S, Miligos D, Creatsas G, Sourla A and Koutsilieris M: Urokinase-type plasminogen activator and insulin-like growth factor-binding protein 3 mRNA expression in endometriotic lesions and eutopic endometrium: implications for the pathophysiology of endometriosis. Ann New York Acad Sci, 997: 223-229, 2003.
28. Kettel LM, Murphy AA, Morales AJ and Yen SS: Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids. Hum Reprod 9: 116-20, 1994.
29. Schneider CC, Gibb RK, Taylor DD, Wan T and Gercel-Taylor C: Inhibition of endometrial cancer cell lines by mifepristone (RU486). J Soc Gynecol Invest 5: 334-338, 1998.
30. Newfield RS, Spitz IM, Isacson C and New M: Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia. Clin Endocrinol 54: 399-404, 2001.
31. Murphy AA, Zhou MH, Malkapuram S, Santanam N, Parthasarathy S and Sidell N: RU486-induced growth inhibition of human endometrial cells. Fertil Steril 74: 1014-9, 2000.